InvestorsHub Logo
Followers 19
Posts 531
Boards Moderated 0
Alias Born 07/13/2022

Re: CrashOverride post# 536305

Monday, 11/21/2022 7:47:46 AM

Monday, November 21, 2022 7:47:46 AM

Post# of 729921
Realistically, given the slow pace of recent events and the limitations on management's time and attention and staff and the reality of regulators who have many other fish to fry besides NWBO, I think the most we can expect before the end of the year is an announcement that commercial approval has been granted to Advent for manufacture of cell and gene therapy products in Sawston.

That, and the annual shareholders meeting.

Pretty sure the rest will have to wait until next year.

But share price may continue to accelerate as large mainstream press outlets around the world (New York, LA, Tokyo, Berlin, Montreal, etc.) pile on and follow the medical breakthrough story.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News